Related Experiment Video
Updated: Jun 6, 2026

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
Published on: December 5, 2019
Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2
Jonathan Shloush1, John E Vlassov, Ian Engson
1Department of Biology, York University, Toronto, Ontario M3J 1P3, Canada.
Abstract:
The tumor suppressor p53 maintains genome stability and prevents malignant transformation by promoting cell cycle arrest and apoptosis. Both Mdm2 and Pirh2 have been shown to ubiquitylate p53 through their RING domains, thereby targeting p53 for proteasomal degradation. Using structural and functional analyses, here we show that the Pirh2 RING domain differs from the Mdm2 RING domain in its oligomeric state, surface charge distribution, and zinc coordination scheme. Pirh2 also possesses weaker E3 ligase activity toward p53 and directs ubiquitin to different residues on p53. NMR and mutagenesis studies suggest that whereas Pirh2 and Mdm2 share a conserved E2 binding site, the seven C-terminal residues of the Mdm2 RING directly contribute to Mdm2 E3 ligase activity, a feature unique to Mdm2 and absent in the Pirh2 RING domain. This comprehensive analysis of the Pirh2 and Mdm2 RING domains provides structural and mechanistic insight into p53 regulation by its E3 ligases.
Insights
The E3 ligases Mdm2 and Pirh2 regulate the tumor suppressor p53. Structural analysis reveals distinct mechanisms for Pirh2 and Mdm2 RING domains in p53 ubiquitylation and degradation.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The tumor suppressor p53 is crucial for maintaining genome stability and preventing cancer.
- Mdm2 and Pirh2 are E3 ligases that target p53 for degradation via ubiquitylation.
- Understanding the structural and functional differences of these E3 ligases is key to comprehending p53 regulation.
Purpose of the Study:
- To structurally and functionally compare the RING domains of Pirh2 and Mdm2.
- To elucidate the distinct mechanisms by which Pirh2 and Mdm2 regulate p53 ubiquitylation and degradation.
- To provide mechanistic insights into p53 regulation by its E3 ligases.
Main Methods:
- Structural analysis of Pirh2 and Mdm2 RING domains.
- Functional assays to assess E3 ligase activity.
- Nuclear Magnetic Resonance (NMR) spectroscopy.
- Site-directed mutagenesis studies.
Main Results:
- The Pirh2 RING domain exhibits unique oligomeric state, surface charge, and zinc coordination compared to Mdm2.
- Pirh2 displays weaker E3 ligase activity towards p53 and ubiquitinates different p53 residues than Mdm2.
- While sharing an E2 binding site, Mdm2's C-terminal residues are essential for its E3 ligase activity, a feature absent in Pirh2.
Conclusions:
- Pirh2 and Mdm2 possess distinct structural and functional properties in their RING domains.
- These differences dictate differential ubiquitylation and degradation of p53.
- The study provides critical structural and mechanistic insights into the regulation of p53 by its E3 ligases, Mdm2 and Pirh2.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The Contractile Ring
A small GTPase, RhoA, controls the function and assembly of the contractile ring. RhoA belongs to the Ras superfamily of proteins. The activation of formins by RhoA promotes...

